M. Welsh

1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat.

M. Sporn, A. Roberts, M. Uskoković, 1994, Cancer research.

A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)

James O. Jones, A. Matakidou, E. Sala, 2022, British Journal of Cancer.

Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study

J. Bartlett, C. Poole, L. Hopcroft, 2023, Breast Cancer Research and Treatment.